PubRank
Search
About
Pradipsinh K Rathod
Author PubWeight™ 52.21
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Chemical genetics of Plasmodium falciparum.
Nature
2010
5.52
2
A microfluidic model for single-cell capillary obstruction by Plasmodium falciparum-infected erythrocytes.
Proc Natl Acad Sci U S A
2003
2.48
3
Divergent regulation of dihydrofolate reductase between malaria parasite and human host.
Science
2002
2.11
4
Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential.
J Med Chem
2011
1.94
5
Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice.
J Med Chem
2009
1.87
6
High-throughput screening for potent and selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
J Biol Chem
2005
1.73
7
Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum.
J Med Chem
2008
1.67
8
Regulatory hotspots in the malaria parasite genome dictate transcriptional variation.
PLoS Biol
2008
1.47
9
Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy.
Infect Disord Drug Targets
2010
1.44
10
A genetically hard-wired metabolic transcriptome in Plasmodium falciparum fails to mount protective responses to lethal antifolates.
PLoS Pathog
2008
1.37
11
Structural plasticity of malaria dihydroorotate dehydrogenase allows selective binding of diverse chemical scaffolds.
J Biol Chem
2009
1.32
12
Malarial dihydroorotate dehydrogenase. Substrate and inhibitor specificity.
J Biol Chem
2002
1.29
13
Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice.
J Med Chem
2011
1.28
14
Microfluidic modeling of cell-cell interactions in malaria pathogenesis.
PLoS Pathog
2007
1.25
15
Asexual populations of the human malaria parasite, Plasmodium falciparum, use a two-step genomic strategy to acquire accurate, beneficial DNA amplifications.
PLoS Pathog
2013
1.25
16
Yeast dihydroorotate dehydrogenase as a new selectable marker for Plasmodium falciparum transfection.
Mol Biochem Parasitol
2011
1.24
17
Malaria in South Asia: prevalence and control.
Acta Trop
2012
1.23
18
Resistance to a protein farnesyltransferase inhibitor in Plasmodium falciparum.
J Biol Chem
2005
1.18
19
Histone acetyltransferase inhibitor anacardic acid causes changes in global gene expression during in vitro Plasmodium falciparum development.
Eukaryot Cell
2008
1.15
20
Deformability limits of Plasmodium falciparum-infected red blood cells.
Cell Microbiol
2009
1.14
21
Analysis of flavin oxidation and electron-transfer inhibition in Plasmodium falciparum dihydroorotate dehydrogenase.
Biochemistry
2008
1.13
22
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo.
PLoS Negl Trop Dis
2008
1.10
23
Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferase.
Mol Biochem Parasitol
2006
0.99
24
Malaria-attributed death rates in India.
Lancet
2011
0.97
25
Fluorine modulates species selectivity in the triazolopyrimidine class of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors.
J Med Chem
2014
0.96
26
Kinetics and ligand-binding preferences of Mycobacterium tuberculosis thymidylate synthases, ThyA and ThyX.
PLoS One
2008
0.95
27
Prodrug activation by Cryptosporidium thymidine kinase.
J Biol Chem
2010
0.94
28
Cell-free production of functional Plasmodium falciparum dihydrofolate reductase-thymidylate synthase.
Mol Biochem Parasitol
2006
0.93
29
Malaria evolution in South Asia: knowledge for control and elimination.
Acta Trop
2012
0.91
30
Catalytic and ligand-binding characteristics of Plasmodium falciparum serine hydroxymethyltransferase.
Mol Biochem Parasitol
2009
0.89
31
The crystal structure and activity of a putative trypanosomal nucleoside phosphorylase reveal it to be a homodimeric uridine phosphorylase.
J Mol Biol
2010
0.88
32
Stochastic versus stable transcriptional differences on Plasmodium falciparum DNA microarrays.
Int J Parasitol
2002
0.84
33
Microfluidic approaches to malaria pathogenesis.
Cell Microbiol
2008
0.84
34
Prized malaria drug target nailed.
Nat Struct Biol
2003
0.84
35
Estimating physical splenic filtration of Plasmodium falciparum-infected red blood cells in malaria patients.
Cell Microbiol
2012
0.83
36
Bioisosteric transformations and permutations in the triazolopyrimidine scaffold to identify the minimum pharmacophore required for inhibitory activity against Plasmodium falciparum dihydroorotate dehydrogenase.
J Med Chem
2012
0.81
37
Differential drug binding by the highly conserved Plasmodium falciparum thymidylate synthase.
Mol Biochem Parasitol
2005
0.80
38
A nondiscriminating glutamyl-tRNA synthetase in the plasmodium apicoplast: the first enzyme in an indirect aminoacylation pathway.
J Biol Chem
2013
0.79
39
A microfluidic system to study cytoadhesion of Plasmodium falciparum infected erythrocytes to primary brain microvascularendothelial cells.
Lab Chip
2011
0.79
40
Clonal variants of Plasmodium falciparum exhibit a narrow range of rolling velocities to host receptor CD36 under dynamic flow conditions.
Eukaryot Cell
2013
0.78
41
Expression of functional Plasmodium falciparum enzymes using a wheat germ cell-free system.
Eukaryot Cell
2013
0.77